A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer
NCT ID: NCT01215526
Last Updated: 2015-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
274 participants
OBSERVATIONAL
2010-10-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Safety of Firmagon®
NCT00930319
Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
NCT01861236
A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON
NCT01234350
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
NCT02440802
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
NCT06450106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeroen Bosch Ziekenhuis, locatie Carolus
's-Hertogenbosch, , Netherlands
Flevoziekenhuis
Almere Stad, , Netherlands
Bovenij Ziekenhuis
Amsterdam, , Netherlands
Wilhelminaziekenhuis
Assen, , Netherlands
Rode Kruis Ziekenhuis
Beverwijk, , Netherlands
Tergooiziekenhuizen
Blaricum, , Netherlands
Amphia Ziekenhuis
Breda, , Netherlands
Ljsselland Ziekenhuis
Capelle aan den IJssel, , Netherlands
Reinier de Graaf Groep
Delft, , Netherlands
Deventer Ziekenhuis
Deventer, , Netherlands
Slingeland Ziekenhuis
Doetinchem, , Netherlands
Alb.Schweitzer Ziekenhuis, loc. Dordwijk
Dordrecht, , Netherlands
Gelderse Vallei, loc. Barneveld
Ede, , Netherlands
Admiraal de Ruyter Ziekenhuis
Flushing, , Netherlands
St. Anna Ziekenhuis
Geldrop, , Netherlands
Admiraal de Ruyter Ziekenhuis
Goes, , Netherlands
Rivas Beatrixziekenhuis
Gorinchem, , Netherlands
Het Groene Hart Ziekenhuis
Gouda, , Netherlands
Buitenpolikliniek
Groenlo, , Netherlands
Martini Ziekenhuis
Groningen, , Netherlands
Ziekenhuis St Jansdal
Harderwijk, , Netherlands
Elkerliek Ziekenhuis
Helmond, , Netherlands
Tergooiziekenhuizen
Hilversum, , Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, , Netherlands
LUMC
Leiden, , Netherlands
Rijnland Ziekenhuis
Leiderdorp, , Netherlands
MUMC
Maastricht, , Netherlands
Ziekenhuis Bernhoven, loc. Oss
Oss, , Netherlands
Waterland Ziekenhuis
Purmerend, , Netherlands
Franciscus Ziekenhuis
Roosendaal, , Netherlands
Havenziekenhuis
Rotterdam, , Netherlands
Vlietland Ziekenhuis
Rotterdam, , Netherlands
Orbis Medisch Centrum
Sittard-Geleen, , Netherlands
Alb. Schweitzer Ziekenhuis loc. Sliedrecht
Sliedrecht, , Netherlands
Antonius Ziekenhuis
Sneek, , Netherlands
Ruwaard v Putten/vWeel Bethesda Zkhs
Spijkenisse, , Netherlands
Zorgzaam Ziekenhuis
Terneuzen, , Netherlands
Hagaziekenhuis loc. Leyweg
The Hague, , Netherlands
Hagaziekenhuis loc. Sportlaan
The Hague, , Netherlands
Ziekenhuis Rivierenland
Tiel, , Netherlands
Antonius Ziekenhuis, loc. Oudenrijn
Utrecht, , Netherlands
Diakonessenhuis Utrecht
Utrecht, , Netherlands
Ziekenhuis Bernhoven, loc. Veghel
Veghel, , Netherlands
Maxima Medisch Centrum
Veldhoven, , Netherlands
St. Jans Gasthuis
Weert, , Netherlands
Albert Schweitzer Ziekenhuis
Zwijndrecht, , Netherlands
Isala Klinieken
Zwolle, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FE200486 CS46
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.